A Convenient Route to 1,3,4-Thiadiazoles,Thiazolidinone, Thiazoles,Pyridones, Coumarins,Triazolo[5,1-c]triazines,and Pyrazolo[5,1-c]triazines Incorporating Pyrazolone Moiety and Their Use as Antimicrobial Agents

Condensation of 4-acetyl-5-methyl-2-phenyl-2,4-dihydropyrazol-3-one (1) with hydrazine derivatives (2a–d) afforded hydrazone derivatives (3a–d), which reacted with alkyl halides 4a–c to give bis(alkylthio)methylene derivatives (5a–e). Also, 3a,b reacted with hydrazonyl halides 6a–d to give 1,3,4-thiadiazole (7a–d). Cyclization of 3c with ethyl bromoacetate and haloketones gave thiazolidinone and thiazole derivatives (8, 10a,b) respectively. Treatment of hydrazone (3d) with benzylidine malononitrile 13a,b gave pyridine (14a,b). In addition, cyclocondensation of 3d with phenolic aldehydes furnished coumarin derivatives (16a–c). Coupling of 3d with heterocyclic diazonium salts gave triazol[5,1-c]triazine (20) and pyrazolo[5,1-c]triazine (22). Some of the prepared products showed potent antimicrobial activity.     

Synthesis of new (pyrazol-1-yl)(7-nitro-1h-indol-2-yl)ketone derivatives

The condensation of 7-nitroindole-2-carbohydrazide derivatives with acetylacetone lead to (pyrazol-1-yl)(7-nitroindol-2-yl)ketones.     

Multi‐component Reactions,Solvent‐free Synthesis of Substituted Pyrano‐pyridopyrimidine under Different Conditions Using ZnO Nanoparticles

2‐Amino‐4‐(4‐substitutedphenyl)‐5‐oxo‐4H,5H‐pyrano[2,3‐d]pyrido[1,2‐a]pyrimidine‐3‐carbonitrile‐derivatives 2–12 were synthesized via multi‐component condensation reactions of different aromatic aldehydes, 3H‐pyrido[1,2‐a]pyrimidine‐2,4‐dione 1 , and malononitrile by using ZnO nanoparticles as green chemistry, environmentally friendly catalyst under solvent‐free conditions. The present work creates a variety of biologically active heterocyclic compounds in excellent yield and a short time. The structures of all synthesized compounds were elucidated with the elemental analyses, IR, ¹H NMR, and mass spectral data.     

New hybrid polyoxometalate/polymer composites for photodegradation of eosin dye

New polyoxometalate (POM)/polymer hybrid composites were prepared by photopolymerization under mild conditions for suitable photocatalytic processes. Polyoxometalates were incorporated in special photosensitive resins, which were photopolymerized under visible light to obtain new materials with photocatalytic activity for dye removal. The synthesized composites were characterized by real‐time FT‐IR, and the photocatalytic ability was investigated on Eosin‐Y removal using photolysis under near UV irradiation. Interestingly, the polyoxometalates keep their photocatalytic properties, while incorporated into the polymeric matrix since very high conversion rates of Eosin‐Y were achieved. Indeed, degradation efficiencies of about 98% and 93% were registered when using H₃PMo₁₂O₄₀/polymer and 94% for SiMo₁₂O₄₀(IPh₂)₄/polymer composites, respectively. These first results reported in this article show that the new synthesized POM/polymer composites could be considered as promising materials for green and more suitable organic dye removal from aqueous solutions. © 2019 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2019, 57, 1538–1549     

Synthesis,X-ray powder structure,and magnetic properties of layered NiII methylphosphonate, [Ni(CH3PO3)(H2O)], and NiII octadecylphosphonate, [Ni(CH3-(CH2)17-PO3)(H2O)

[Ni(CH(3)PO(3))(H(2)O)] (1) and [Ni(CH(3)-(CH(2))(17)-PO(3))(H(2)O)] (2) were synthesised by reaction of NiCl(2).6 H(2)O and the relevant phosphonic acid in water in presence of urea. The compounds were characterised by elemental and thermogravimetric analyses, UV-visible and IR spectroscopy, and their magnetic properties were studied by using a SQUID magnetometer. The crystal structure of 1 was determined "ab initio" from X-ray powder diffraction data and refined by the Rietveld method. The crystals of 1 are orthorhombic, space group Pmn2(1), with a=5.587(1), b=8.698(1), c=4.731(1) A. The compound has a hybrid, layered structure made up of alternating inorganic and organic layers along the b direction of the unit-cell. The inorganic layers consist of Ni(II) ions octahedrally coordinated by five phosphonate oxygen atoms and one oxygen atom from the water molecule. These layers are separated by bilayers of methyl groups and van der Waals contacts are established between them. A preliminary structure characterisation of compound 2 suggests the crystallisation in the orthorhombic system with the following unit-cell parameters: a=5.478(7), b=42.31(4), c=4.725(3) A. The oxidation state of the Ni ion in both compounds is +2, and the electronic configuration is d(8) (S=1), as determined from static magnetic susceptibility measurements above 50 K. Compound 1 obeys the Curie-Weiss law at temperatures above 50 K; the Curie (C) and Weiss (theta) constants were found to be 1.15 cm(3) K mol(-1) and -32 K, respectively. The negative value of theta indicates an antiferromagnetic exchange coupling between near-neighbouring Ni(II) ions. No sign of 3D antiferromagnetic long-range order is observed down to T=5 K, the lowest measured temperature. Compound 2 is paramagnetic above T=50 K, and the values of C and theta were found to be 1.25 cm(3) K mol(-1) and -24 K, respectively. Below 50 K the magnetic behavior of 2 is different from that of 1. Zero-field cooled (zfc) and field-cooled (fc) magnetisation plots do not overlap below T=21 K. The irreversible magnetisation, DeltaM(fc-zfc), obtained as a difference from fc and zfc plots starts to increase at T=20 K, on lowering the temperature, and it becomes steady at T=5 K. The presence of spontaneous magnetisation below T=20 K indicates a transition to a weak-ferromagnetic state for compound 2.     

Two‐dimensional separation techniques using supercritical fluid chromatography

High‐resolution separation systems are essential for the analysis of complex mixtures in a wide variety of application areas. To increase resolution, multidimensional chromatographic techniques have been one key solution. Supercritical fluid chromatography provides a unique opportunity in these multidimensional separations based on its potential for high solvent compatibility, rapid duty cycles, and orthogonality to other separation modes. This review focuses on two‐dimensional chromatography methods from the past decade that use supercritical fluid chromatography because of these advantages. Valving schemes and modulation strategies used to interface supercritical fluid chromatography with other liquid chromatography and gas chromatography techniques are described. Particular applications of multidimensional separations using supercritical fluid chromatography for the analysis of oils and chiral separations of pharmaceutical compounds are highlighted. Limitations of and a potential trajectory for supercritical fluid chromatography in this field are also discussed.     

Design,Synthesis, Molecular Modeling and Antitumor Evaluation of Novel Indolyl-Pyrimidine Derivatives with EGFR Inhibitory Activity

Scaffolds hybridization is a well-known drug design strategy for antitumor agents. Herein, series of novel indolyl-pyrimidine hybrids were synthesized and evaluated in vitro and in vivo for their antitumor activity. The in vitro antiproliferative activity of all compounds was obtained against MCF-7, HepG2, and HCT-116 cancer cell lines, as well as against WI38 normal cells using the resazurin assay. Compounds 1–4 showed broad spectrum cytotoxic activity against all these cancer cell lines compared to normal cells. Compound 4g showed potent antiproliferative activity against these cell lines (IC₅₀ = 5.1, 5.02, and 6.6 μM, respectively) comparable to the standard treatment (5-FU and erlotinib). In addition, the most promising group of compounds was further evaluated for their in vivo antitumor efficacy against EAC tumor bearing mice. Notably, compound 4g showed the most potent in vivo antitumor activity. The most active compounds were evaluated for their EGFR inhibitory (range 53–79%) activity. Compound 4g was found to be the most active compound against EGFR (IC₅₀ = 0.25 µM) showing equipotency as the reference treatment (erlotinib). Molecular modeling study was performed on compound 4g revealed a proper binding of this compound inside the EGFR active site comparable to erlotinib. The data suggest that compound 4g could be used as a potential anticancer agent.